Author Index

Search or browse for an author across our entire electronic archive

Search results for: Y
Results 221 - 230 of 435 shown below

  • Yeasmin, S

    N Nakayama, K Nakayama, S Yeasmin, M Ishibashi, A Katagiri, K Iida, M Fukumoto and K Miyazaki

    KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer

    advance online publication, 2008-11-18 00:00:00.000;

    doi:10.1038/sj.bjc.6604783

  • Yeates, D

    M J Goldacre, J D Abisgold, V Seagroatt and D Yeates

    Cancer after cholecystectomy: record-linkage cohort study

    advance online publication, 2005-03-15 00:00:00.000;

    doi:10.1038/sj.bjc.6602392

  • M J Goldacre, C J Wotton, V Seagroatt and D Yeates

    Cancer following hip and knee arthroplasty: record linkage study

    doi:10.1038/sj.bjc.6602511

  • Yee, A S

    K M Rieger-Christ, L Ng, R S Hanley, O Durrani, H Ma, A S Yee, J A Libertino and I C Summerhayes

    Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential

    advance online publication, 2005-06-07 00:00:00.000;

    doi:10.1038/sj.bjc.6602651

  • Yee, D

    D Yee

    Targeting insulin-like growth factor pathways

    advance online publication, 2006-01-31 00:00:00.000;

    doi:10.1038/sj.bjc.6602963

  • S A Byron, K B Horwitz, J K Richer, C A Lange, X Zhang and D Yee

    Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells

    advance online publication, 2006-10-17 00:00:00.000;

    doi:10.1038/sj.bjc.6603354

  • H Zhang, X Zeng, Q Li, M Gaillard-Kelly, C R Wagner and D Yee

    Fluorescent tumour imaging of type I IGF receptor in vivo: comparison of antibody-conjugated quantum dots and small-molecule fluorophore

    advance online publication, 2009-06-02 00:00:00.000;

    doi:10.1038/sj.bjc.6605103

  • Yeend, S J

    K B Pittman, I N Olver, B Koczwara, D Kotasek, W K Patterson, D M Keefe, C S Karapetis, F X Parnis, S Moldovan, S J Yeend and T J Price

    Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study

    advance online publication, 2006-10-31 00:00:00.000;

    doi:10.1038/sj.bjc.6603440

  • Yeger, H

    A Marks, D R Sutherland, D Bailey, J Iglesias, J Law, M Lei, H Yeger, D Banerjee and R Baumal

    Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours

    doi:10.1038/sj.bjc.6690393

  • Yeh, C N

    C H Lee, C J Chang, Y J Lin, C N Yeh, M F Chen and S Y Hsieh

    Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma

    advance online publication, 2009-05-12 00:00:00.000;

    doi:10.1038/sj.bjc.6605063

  • Yeh, C-H

    C-H Yeh, Y-C Chiang, L Lin, C-P Yang, L-C Chien, M A Weaver and H-L Chuang

    Clinical factors associated with fatigue over time in paediatric oncology patients receiving chemotherapy

    advance online publication, 2008-06-24 00:00:00.000;

    doi:10.1038/sj.bjc.6604434

  • Yeh, C-S

    C-H Wu, Y-F Chen, J-Y Wang, M-C Hsieh, C-S Yeh, S-T Lian, S-J Shin and S-R Lin

    Mutant K-ras oncogene regulates steroidogenesis of normal human adrenocortical cells by the RAF-MEK-MAPK pathway

    doi:10.1038/sj.bjc.6600589

  • Yeh, G C

    V Trapani, V Patel, C-O Leong, H P Ciolino, G C Yeh, C Hose, J B Trepel, M F G Stevens, E A Sausville and A I Loaiza-Pérez

    DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells

    doi:10.1038/sj.bjc.6600722

  • H P Ciolino and G C Yeh

    The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor

    doi:10.1038/sj.bjc.6690216